{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:14:39Z","timestamp":1792102479688,"version":"4.4.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction and importance:<\/jats:title>\n            <jats:p>Systemic lupus erythematosus (SLE) is a systemic immune disease, presented with a broad spectrum of clinical manifestations. The occurrence of interstitial lung disease (ILD) as the initial manifestation of SLE is very rare.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>The authors present the case of a 6-year-old girl who presented with symptoms of fatigue, fever, oral ulcers, and dry cough with difficulty breathing. On physical examination, the patient had fever and oral ulcers, in addition of acute phase reactant analysis, positive ANA, and double-stranded DNA. Chest computed tomography images showed nonspecific interstitial pneumonia + organizing pneumonia pattern, leading to the diagnosis of onset of SLE with ILD. The patient was treated with steroids and azathioprine for 1 year, and the radiological and immunological resolution was noted. However, the patient continued to cough, have difficulty breathing, and was readmitted to the hospital due to SLE recurrence after 1 year of follow-up. Despite continued corticosteroid therapy and monthly administration of steroids and cyclophosphamide for 6 months, the patient\u2019s respiratory symptoms and chest radiography results did not improve significantly. The patient was then prescribed a daily regimen of cyclophosphamide and pirfenidone, which was found to be effective in reducing the steroid dose and achieving remission after 1 year of follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical discussion:<\/jats:title>\n            <jats:p>Treatment of connective tissue disease-associated ILD is difficult due to a lack of treatment data.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This case provided evidence of the efficacy of combination therapy of pirfenidone and cyclophosphamide for refractory connective tissue disease-associated ILD in young children.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000001677","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T08:00:23Z","timestamp":1704355223000},"page":"6686-6688","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Successful treatment of refractory interstitial lung disease with cyclophosphamide and pirfenidone in a new onset of juvenile SLE: a case report"],"prefix":"10.1097","volume":"86","author":[{"given":"Raghad","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Damascus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naram","family":"Khalayli","sequence":"additional","affiliation":[{"name":"Damascus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahaf","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Damascus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Fahda","sequence":"additional","affiliation":[{"name":"Damascus University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassel","family":"Salman","sequence":"additional","affiliation":[{"name":"Oakland University, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysoun","family":"Kudsi","sequence":"additional","affiliation":[{"name":"Damascus University, Damascus, Syria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/MS9.0000000000000477","article-title":"Systemic lupus erythematosus disease activity and neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: a cross-sectional case-control study","volume":"85","author":"Abdalhadi","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.3390\/ijms24119388","article-title":"Interstitial lung disease in systemic lupus erythematosus and systemic sclerosis: how can we manage the challenge?","volume":"24","author":"Richter","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/0961203320967439","article-title":"Bronchiolitis obliterans organizing pneumonia as the pulmonary manifestation of lupus: A review of three cases","volume":"30","author":"Baisya","year":"2021","journal-title":"Lupus"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ppul.20224","article-title":"Bronchiolitis obliterans organizing pneumonia as an initial manifestation in systemic lupus erythematosus","volume":"40","author":"Takada","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"708463","DOI":"10.3389\/fimmu.2021.708463","article-title":"Case report: successful treatment of refractory interstitial lung disease with cyclosporine a and pirfenidone in a child with SLE","volume":"12","author":"Deng","year":"2021","journal-title":"Front Immunol"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"107329","DOI":"10.1016\/j.rmed.2023.107329","article-title":"Efficacy and safety of antifibrotic agents in the treatment of CTD-ILD and RA-ILD: a systematic review and meta-analysis","volume":"216","author":"Yang","year":"2023","journal-title":"Respir Med"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.3390\/jcm11226714","article-title":"Systemic lupus erythematosus and lung involvement: a comprehensive review","volume":"11","author":"Shin","year":"2022","journal-title":"J Clin Med"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11926-021-00985-0","article-title":"Systemic lupus erythematosus in children and young people","volume":"23","author":"Charras","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"180076","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur Respir Rev"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1038\/s41598-019-43782-7","article-title":"Analysis of systemic lupus erythematosus-related interstitial pneumonia: a retrospective multicentre study","volume":"9","author":"Enomoto","year":"2019","journal-title":"Sci Rep"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7573\/dic.2020-9-1","article-title":"Efficacy of cyclophosphamide in treating connective tissue disease-related interstitial lung diseases","volume":"10","author":"Nucera","year":"2021","journal-title":"Drugs Context"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.3390\/ijms24097849","article-title":"Efficacy of pirfenidone and nintedanib in interstitial lung diseases other than idiopathic pulmonary fibrosis: a systematic review","volume":"24","author":"Amati","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"1900399","DOI":"10.1183\/13993003.00399-2019","article-title":"Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis","volume":"54","author":"Glassberg","year":"2019","journal-title":"Eur Respir J"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/rccm.201701-0091OC","article-title":"Pirfenidone reduces respiratory-related hospitalizations in idiopathic pulmonary fibrosis","volume":"196","author":"Ley","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/pbc.25041","article-title":"Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas","volume":"61","author":"Widemann","year":"2014","journal-title":"Pediatr Blood Cancer"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:08:28Z","timestamp":1754485708000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000001677","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"2023-09-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}